The company had posted a net profit of Rs 66.2 crore for the corresponding period of the previous fiscal, Natco Pharma said in a filing to BSE.
Consolidated total revenue of the company stood at Rs 432.2 crore for the quarter under review. It was Rs 471.1 crore for the same period a year ago.
Shares of Natco Pharma today settled at Rs 996.70 per scrip, up 2.28 per cent on BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content